Stock of The Day: Landauer Inc’s Trend Up, Especially After Today’s 52-Week High Milestone

Stock of The Day: Landauer Inc's Trend Up, Especially After Today's 52 Week High Milestone

The stock of Landauer Inc (NYSE:LDR) hit a new 52-week high and has $127.39 target or 149.00% above today’s $51.16 share price. The 5 months bullish chart indicates low risk for the $497.48M company. The 1-year high was reported on Nov, 17 by Barchart.com. If the $127.39 price target is reached, the company will be worth $741.25 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 49,911 shares traded hands or 28.90% up from the average. Landauer Inc (NYSE:LDR) has risen 48.85% since April 15, 2016 and is uptrending. It has outperformed by 44.22% the S&P500.

Analysts await Landauer Inc (NYSE:LDR) to report earnings on December, 12. They expect $0.29 EPS, down 27.50% or $0.11 from last year’s $0.4 per share. LDR’s profit will be $2.82M for 44.10 P/E if the $0.29 EPS becomes a reality. After $0.49 actual EPS reported by Landauer Inc for the previous quarter, Wall Street now forecasts -40.82% negative EPS growth.

Landauer Inc (NYSE:LDR) Ratings Coverage

Out of 2 analysts covering Landauer (NYSE:LDR), 0 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 0 are positive. Landauer has been the topic of 2 analyst reports since August 16, 2016 according to StockzIntelligence Inc. As per Friday, July 1, the company rating was downgraded by Hilliard Lyons. The stock has “Neutral” rating given by Sidoti on Tuesday, August 16.

According to Zacks Investment Research, “Landauer Inc. is the world’s leading provider of analytical services to determine occupational and environmental radiation exposure. For more than fifty years, the company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, and other industries in which radiation poses a potential threat to employees. Landauer’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from clients, and the analysis and reporting of exposure findings. The company provides its services to one.five million people in the United States, Japan, France, the United Kingdom, Brazil, Canada, China, Australia and other countries.”

Insitutional Activity: The institutional sentiment decreased to 1.13 in 2016 Q2. Its down 0.36, from 1.49 in 2016Q1. The ratio dived, as 8 funds sold all Landauer Inc shares owned while 37 reduced positions. 15 funds bought stakes while 36 increased positions. They now own 8.13 million shares or 2.71% less from 8.35 million shares in 2016Q1.
The Pennsylvania-based Vanguard Inc has invested 0% in Landauer Inc (NYSE:LDR). Wasatch last reported 0.14% of its portfolio in the stock. Gsa Cap Ltd Liability Partnership last reported 26,621 shares in the company. Crawford Inv Counsel Inc accumulated 0.06% or 39,564 shares. Boston Prtnrs has invested 0.01% of its portfolio in Landauer Inc (NYSE:LDR). Pinebridge Invests Lp, a New York-based fund reported 1,125 shares. Us Commercial Bank De holds 0% of its portfolio in Landauer Inc (NYSE:LDR) for 195 shares. The California-based Blackrock Institutional Na has invested 0% in Landauer Inc (NYSE:LDR). Moreover, Ridgeworth Management Limited Com has 0.22% invested in Landauer Inc (NYSE:LDR) for 641,957 shares. Cadence Capital Mngmt Limited Co has invested 0.06% of its portfolio in Landauer Inc (NYSE:LDR). Nuveen Asset Mngmt Lc, a Illinois-based fund reported 72,223 shares. Moreover, Gabelli Funds Limited Liability Co has 0.04% invested in Landauer Inc (NYSE:LDR) for 165,000 shares. Blackrock Advsr Llc last reported 315,499 shares in the company. The Washington-based Parametric Limited Liability Com has invested 0% in Landauer Inc (NYSE:LDR). Gamco Invsts Inc Et Al has invested 0.02% of its portfolio in Landauer Inc (NYSE:LDR).

More notable recent Landauer Inc (NYSE:LDR) news were published by: Prnewswire.com which released: “Landauer, Inc. Appoints Teri Fontenot to Board of Directors” on September 28, 2016, also Prnewswire.com with their article: “Landauer, Inc. Names Mike Kaminski President And Chief Executive Officer …” published on August 26, 2015, Prnewswire.com published: “Landauer, Inc. Reports Fiscal 2015 Fourth Quarter And Full Year Results” on December 14, 2015. More interesting news about Landauer Inc (NYSE:LDR) were released by: Prnewswire.com and their article: “Landauer, Inc. Announces Financial Leadership Transition” published on April 15, 2015 as well as Thestreet.com‘s news article titled: “Landauer Inc Stock Downgraded (LDR)” with publication date: August 06, 2014.

LDR Company Profile

Landauer, Inc. (Landauer), incorporated on November 23, 1987, is a well-known provider of technical and analytical services to determine occupational and environmental radiation exposure. The Firm is a domestic well-known provider of outsourced medical physics services and a well-known provider of radiology related medical products. It operates in three business divisions: Radiation Measurement, Medical Physics and Medical Products. The Company’s services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company’s services are provided to approximately 1.8 million individuals around the globe. In addition to providing analytical services, the Company sells dosimetry detectors and reading equipment to clients that want to manage their own dosimetry programs, or into smaller international markets. The Firm offers its service for measuring the dosages of x-ray, gamma radiation and other penetrating ionizing radiations. The Company’s technology is marketed under the trade names Luxel+ and InLight.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Leave a Comment